You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動 | 利好疊加 眾生藥業漲近5%
格隆匯 08-05 10:17
格隆匯8月5日丨眾生藥業(002317.SZ)漲4.94%,報15.5元,總市值126億元。眾生藥業4日公吿稱,近日,公司控股子公司眾生睿創口服抗新型冠狀病毒3CL蛋白酶抑制劑RAY1216片Ⅰ期臨牀試驗,已按臨牀研究計劃完成全部受試者的入組和臨牀觀察,試驗結果顯示安全性和藥代動力學特性良好,達到預期研究目的。另外,眾生藥業3日公佈,近日,廣東眾生藥業股份有限公司收到日本特許廳(Japan Patent Office)頒發的專利證書。專利名稱為FGFR4阻害剤、その製造方法及び使用(FGFR4抑制劑及其製備方法和應用)。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account